Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Registry sponsor category
Industry
- Other names
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Company name
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (389)
- A Bioequivalence Study of Capecitabine Tablets
- A Bioequivalence Study of Dasatinib Tablet
- A Bioequivalence Study of Sunitinib Malate Capsules.
- A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
- A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer
- A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes
- A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
- A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients
- A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)
- A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer
- A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
- A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC).
- A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.
- A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors
- A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
- A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer
- A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor
- A Clinical Study of TQB3824 in Subjects With Advanced Cancer
- A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor
- A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps